UNICA IRIS Institutional Research Information System

CARPINIELLO, BERNARDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 366.892
NA - Nord America 30.909
AS - Asia 18.033
SA - Sud America 3.095
AF - Africa 459
OC - Oceania 105
Continente sconosciuto - Info sul continente non disponibili 20
Totale 419.513
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 351.619
US - Stati Uniti d'America 30.290
SG - Singapore 6.855
CN - Cina 6.393
UA - Ucraina 4.013
NL - Olanda 3.194
BR - Brasile 2.469
SE - Svezia 2.252
VN - Vietnam 1.574
FI - Finlandia 1.420
FR - Francia 1.187
DE - Germania 1.180
GB - Regno Unito 1.136
HK - Hong Kong 863
IN - India 471
KR - Corea 455
CA - Canada 420
AR - Argentina 211
BD - Bangladesh 189
RU - Federazione Russa 185
IQ - Iraq 158
TR - Turchia 132
JP - Giappone 131
MX - Messico 119
ID - Indonesia 118
EC - Ecuador 115
ZA - Sudafrica 108
ES - Italia 98
AU - Australia 94
PK - Pakistan 94
PL - Polonia 88
CO - Colombia 82
PH - Filippine 82
MA - Marocco 70
VE - Venezuela 64
EG - Egitto 61
SA - Arabia Saudita 60
IE - Irlanda 59
UZ - Uzbekistan 58
IR - Iran 57
BE - Belgio 54
CH - Svizzera 54
KE - Kenya 50
AT - Austria 48
CL - Cile 48
RO - Romania 45
MY - Malesia 42
PY - Paraguay 41
DZ - Algeria 30
IL - Israele 30
JO - Giordania 30
NO - Norvegia 30
AE - Emirati Arabi Uniti 26
TH - Thailandia 25
PE - Perù 24
TN - Tunisia 24
AZ - Azerbaigian 23
ET - Etiopia 23
BO - Bolivia 22
DK - Danimarca 22
NP - Nepal 22
CZ - Repubblica Ceca 21
LT - Lituania 19
PT - Portogallo 19
LB - Libano 18
UY - Uruguay 17
HU - Ungheria 16
KZ - Kazakistan 16
SN - Senegal 16
TW - Taiwan 16
BG - Bulgaria 15
GR - Grecia 15
MU - Mauritius 15
SK - Slovacchia (Repubblica Slovacca) 15
HR - Croazia 14
NG - Nigeria 14
EU - Europa 13
PS - Palestinian Territory 13
DO - Repubblica Dominicana 12
JM - Giamaica 12
OM - Oman 12
NZ - Nuova Zelanda 11
RS - Serbia 11
AL - Albania 10
PA - Panama 10
EE - Estonia 9
HN - Honduras 9
LV - Lettonia 9
NI - Nicaragua 9
QA - Qatar 9
AO - Angola 8
BH - Bahrain 8
GT - Guatemala 8
CR - Costa Rica 7
GH - Ghana 7
KG - Kirghizistan 7
KW - Kuwait 7
AM - Armenia 6
CI - Costa d'Avorio 6
LU - Lussemburgo 6
Totale 419.402
Salva come PNG Salva come JPEG
Città #
Cagliari 337.161
Uta 8.242
Singapore 3.300
Amsterdam 2.985
Chandler 2.614
Ashburn 2.288
Boardman 2.245
Jacksonville 2.135
Dallas 2.051
Fairfield 1.865
San Jose 1.660
Woodbridge 1.577
Ann Arbor 1.264
Wilmington 1.049
Houston 1.003
Nyköping 966
Beijing 942
Helsinki 797
Hong Kong 778
Hefei 766
Los Angeles 732
Boston 712
Seattle 695
Nanjing 640
Lauterbourg 602
Cambridge 578
Milan 564
Ho Chi Minh City 506
Rome 462
Seoul 430
Buffalo 408
Hanoi 339
The Dalles 307
New York 284
Santa Clara 267
Dearborn 251
Toronto 246
Shanghai 229
São Paulo 211
Shenyang 206
Council Bluffs 190
Tianjin 186
Nanchang 171
Changsha 163
Verona 161
San Diego 155
Hebei 147
Guangzhou 144
Jiaxing 139
Redwood City 124
Chicago 122
Orem 121
Frankfurt am Main 119
Dong Ket 114
Norwalk 113
Orange 102
Jinan 88
Tokyo 87
Zhengzhou 85
Munich 83
London 82
Bologna 81
Redondo Beach 78
Naples 77
Rio de Janeiro 76
Haiphong 75
Washington 75
Florence 73
Chennai 71
Warsaw 68
Phoenix 67
Brooklyn 66
Ningbo 65
Turin 62
Nuremberg 60
Cardiff 58
Sassari 58
Montreal 57
Atlanta 56
Johannesburg 56
Pune 55
Da Nang 54
Hangzhou 54
Nieuwegein 54
Saint Petersburg 54
Baghdad 52
Belo Horizonte 52
Bari 51
Tashkent 47
Brussels 43
Nairobi 43
Padova 42
Mountain View 41
Redmond 41
Dublin 40
Porto Alegre 40
Brasília 39
Stockholm 39
Guayaquil 38
Melbourne 38
Totale 389.249
Salva come PNG Salva come JPEG
Nome #
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 6.669
Violence and mental disorders. A retrospective study of people in charge of a community mental health center 4.474
Mortality in mental disorders: Are we approaching to close the gap respect to other medical specialties? The case of schizophrenia 4.249
Validation of the italian version of the compensatory eating and behaviors in response to alcohol consumption scale (CEBRACS) 4.234
Mental disorders in obese patients with and without metabolic syndrome 3.927
Psychopathology, psychosocial factors and obesity 3.835
The asthma-anxiety connection 3.724
Obesità, sindrome metabolica e comorbidità psichiatriche 3.700
Le psicoterapie 3.683
Obesità e qualità della vita 3.669
The interplay among psychopathology, personal resources, context-related factors and real-life functioning in schizophrenia: stability in relationships after 4 years and differences in network structure between recovered and non-recovered patients 3.669
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder 3.632
Role of palmitoylethanolamide (PEA) in depression: Translational evidence Special Section on “Translational and Neuroscience Studies in Affective Disorders”. Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders 3.620
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.503
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.421
Assessment of eating disorders with the diabetes eating problems survey - revised (DEPS-R) in a representative sample of insulin-treated diabetic patients: a validation study in Italy 3.414
Duration of untreated illness as a key to early intervention in schizophrenia: A review 3.173
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.138
Obesity, alexithymia and psychopathology: A case-control study 3.097
Mental disorders in patients with metabolic syndrome. The key role of central obesity 3.027
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.006
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.880
Il modello alternativo del DSM-5 per i disturbi di personalità 2.697
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.674
Clinical global impression-severity score as a reliable measure for routine evaluation of remission in schizophrenia and schizoaffective disorders 2.671
Obesità e psicopatologia 2.661
Obesità, sindrome metabolica e comorbidità psichiatriche 2.653
Obesità e psicopatologia 2.636
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.597
Obesità, sindrome metabolica e comorbidità psichiatriche 2.590
Biomarkers in aggression 2.540
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.507
Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice 2.480
Obesità e alessitimia 2.399
Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses 2.396
Obesità e comorbidità psichiatrica di Asse I: risultati di uno studio caso – controllo 2.378
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.343
Diagnostic reliability in schizoaffective disorder 2.291
Disturbi da uso di sostanze e malattie dentali: lo stato dell’arte 2.172
Obesità e alessitimia 2.033
The complex relationship between self-reported ‘personal recovery’ and clinical recovery in schizophrenia 2.031
Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report 1.999
Psychiatric comorbidity and quality of life in obese patients. Results from a case-control study 1.998
Obesità, alessitimia e rappresentazione corporea: risultati di uno studio caso – controllo 1.990
Obesity and psychopathology. A study of psychiatric comorbidity among patients attending a specialist obesity unit 1.929
Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study 1.917
Unblending borderline personality and bipolar disorders 1.896
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.884
Clinicians’ attitudes to cardiac function monitoring guidelines during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness 1.876
Obesità e punteggi all’SCL-90-R 1.838
Mental health in transgender individuals: a systematic review 1.837
Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets 1.832
PALIPERIDONE PALMITATE IN ACUTE PATIENTS WITH SCHIZOPHRENIA - TREATMENT RESPONSE, SAFETY AND TOLERABILITY: A PROSPECTIVE FLEXIBLE DOSE STUDY IN PATIENTS PREVIOUSLY UNSUCCESSFULLY TREATED WITH ORAL ANTIPSYCHOTICS 1.830
Disturbi dell'Umore 1.804
Asthma and psychiatric disorders 1.785
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses 1.678
Anatomical distribution and expression of CYP in humans: Neuropharmacological implications 1.667
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.656
Obesità e comorbidità psichiatrica di asse I: studio caso - controllo 1.652
Risk and resilience factors for specific and general psychopathology worsening in people with Eating Disorders during COVID-19 pandemic: a retrospective Italian multicentre study 1.637
First-episode psychosis and migration in Italy (PEP-Ita migration): A study in the Italian mental health services 1.623
Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives 1.622
The relationships of personal resources with symptom severity and psychosocial functioning in persons with schizophrenia: results from the Italian Network for Research on Psychoses study 1.608
Differenze di genere nella remissione e recovery di pazienti schizofrenici e schizoaffettivi: risultati di uno studio di coorte prospettico 1.606
Clinical correlates of age at onset distribution in bipolar disorder: a comparison between diagnostic subgroups 1.592
The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review 1.584
The Italian version of the borderline personality disorder severity index IV: Psychometric properties, clinical usefulness, and possible diagnostic implications 1.569
Impulsivity and aggressiveness in bipolar disorder with co-morbid borderline personality disorder 1.562
Interplay among psychopathologic variables, personal resources, context-related factors, and real-life functioning in individuals with schizophrenia: a network analysis 1.548
Estimating the impact of workplace bullying: humanistic and economic burden among workers with chronic medical conditions 1.542
Il disturbo bipolare e la comorbidità con i disturbi di personalità 1.512
Accuracy of self-assessment of real-life functioning in schizophrenia 1.492
Approccio al trattamento dell’obesità: 5 anni di esperienza in un team multidisciplinare metabolico - psicoeducazionale – motorio 1.476
Personalized psychiatry: Promises and pitfalls 1.471
Prevalence of antipsychotic-induced extrapyramidal symptoms and their association with neurocognition and social cognition in outpatients with schizophrenia in the “real-life” 1.471
How Is the History of Early Traumatic Exposure Associated With the Psychopathological Outcomes of COVID-19 Related Lockdown and Subsequent Re-opening in People With Eating Disorders? 1.460
The modern perspective for long-acting injectables antipsychotics in the patient-centered care of schizophrenia 1.456
Disturbo da sintomi somatici e disturbi correlati 1.453
Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of a prospective cohort study 1.452
Obesità e disturbi d’ansia 1.433
Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy 1.430
Obesità e ansia 1.418
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 1.404
Schizofrenia e disturbo schizoaffettivo: differenze cliniche, di decorso, esito e trattamento 1.390
Big data in severe mental illness: the role of electronic monitoring tools and metabolomics 1.376
Clinicians' adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: A retrospective report on 434 patients with severe mental illness 1.365
Obesità e disturbi di personalità 1.354
Obesità e qualità della vita 1.352
Disturbi della nutrizione e dell'alimentazione 1.345
Haloperidol and loss of gray matter in schizophrenia: Reconciling meta-analytical results with molecular pharmacology 1.342
The link between thyroid autoimmunity (antithyroid peroxidase autoantibodies) with anxiety and mood disorders in the community: a field of interest for public health in the future 1.335
The reciprocal relationship between suicidality and stigma 1.306
Pattern of gene expression in different stages of schizophrenia: Down-regulation of NPTX2 gene revealed by a meta-analysis of microarray datasets 1.305
Obesità e disturbi di personalità: risultati di uno studio caso - controllo 1.285
Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia 1.282
Prevalence and clinical correlates of cognitive symptoms in depression: A naturalistic study 1.268
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.262
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.246
Obesità e disturbi di personalità 1.209
Le cure 1.204
Totale 220.208
Salva come PNG Salva come JPEG
Categoria #
all - tutte 624.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 624.121
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111.814 0 0 0 0 0 0 0 0 0 4.690 4.469 2.655
2021/202220.439 2.074 1.744 1.090 1.523 1.842 1.450 973 905 1.419 1.601 2.815 3.003
2022/202333.545 2.927 2.859 2.970 2.628 2.664 3.452 1.397 6.784 2.294 1.687 2.351 1.532
2023/202444.625 2.576 1.506 2.647 4.157 3.964 7.633 6.465 3.063 2.217 3.347 3.666 3.384
2024/2025107.212 32.267 30.919 9.842 7.522 4.336 4.334 10.309 775 1.515 2.258 1.393 1.742
2025/202629.859 1.896 1.525 4.893 3.559 2.116 2.243 5.445 1.932 4.045 2.205 0 0
Totale 420.738